Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
In Vitro DiagnosticsBiotechnology EquipmentPOC Diagnostics

PUBLISHER: Grand View Research | PRODUCT CODE: 2089826

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 2089826

Point-of-Care Molecular Diagnostics Market Size, Share & Trends Analysis Report By Application (Infectious Diseases, Oncology, Prenatal Testing), By Technology, By Test Location, By End Use, By Region, And Segment Forecasts, 2026 - 2033

PUBLISHED:
PAGES: 161 Pages
DELIVERY TIME: 2-10 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 5950
Printable PDF & Excel (5-User License)
USD 6950
Printable PDF & Excel (Enterprise License)
USD 8950

Add to Cart

Description

Table of Contents

List of Tables

Point-of-Care Molecular Diagnostics Market Summary

The global point-of-care molecular diagnostics market size was valued at USD 8.73 billion in 2025 and is projected to grow from USD 9.28 billion in 2026 to USD 14.47 billion by 2033, at a CAGR of 6.56% from 2026 to 2033. North America dominated the global market and accounted for the largest revenue share of 45.41% in 2025. This market focuses on rapid, accurate molecular testing performed near the patient, enabling timely clinical decision-making.

These platforms are used across various applications, particularly in infectious disease detection, respiratory illnesses, and sexually transmitted infections.

Key Trends Shaping the Point-of-Care (POC) Molecular Diagnostics Market

Portable and Cartridge-Based Systems:

Compact, all-in-one molecular testing platforms with self-contained cartridges are gaining popularity due to ease of use, minimal training requirements, and suitability for decentralized settings.

Multiplex Testing Capabilities:

There is growing adoption of POC devices capable of detecting multiple pathogens from a single sample. This supports faster differential diagnosis, particularly for respiratory infections with overlapping symptoms.

Integration with Digital Health Ecosystems:

POC molecular devices are increasingly being designed with wireless connectivity, enabling real-time data sharing with electronic health records and supporting telemedicine and remote monitoring initiatives.

Expansion Beyond Infectious Diseases:

While infectious disease testing dominates, companies are expanding into new areas such as oncology, genetic screening, and antimicrobial resistance, broadening the clinical utility of POC molecular platforms.

Focus on Low-Resource and Remote Settings:

The development of rugged, battery-powered devices with minimal infrastructure needs is addressing diagnostic gaps in rural, emergency, and mobile care environments, especially in developing countries.

These trends underscore the growing importance of rapid, decentralized diagnostics in clinical decision-making. With continued improvements in portability, connectivity, and test versatility, point-of-care molecular diagnostics are becoming more accessible across diverse healthcare environments. The expansion beyond infectious diseases further broadens their clinical relevance. As healthcare systems prioritize speed and accuracy, these technologies are expected to see sustained demand in developed and developing regions.

Global Point-of-Care Molecular Diagnostics Market Report Segmentation

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global point-of-care molecular diagnostics market report on the basis of application, technology, test location, end use, and region:

  • Technology Outlook (Revenue, USD Billion, 2021 - 2033)
  • PCR-based
  • Genetic Sequencing-based
  • Hybridization-based
  • Microarray-based
  • Application Outlook (Revenue, USD Billion, 2021 - 2033)
  • Infectious Diseases
    • HIV POC
    • Clostridium difficile POC
    • HBV POC
    • Pneumonia or Streptococcus associated infections
    • Respiratory syncytial virus (RSV) POC
    • HPV POC
    • Influenza/Flu POC
    • HCV POC
    • MRSA POC
    • TB and drug-resistant TB POC
    • HSV POC
    • Other Infectious Diseases
  • Oncology
  • Hematology
  • Prenatal Testing
  • Endocrinology
  • Other Applications
  • Test Location Outlook (Revenue, USD Billion, 2021 - 2033)
  • OTC
  • POC
  • End Use Outlook (Revenue, USD Billion, 2021 - 2033)
  • Decentralized Labs
  • Hospitals
  • Home-care
  • Assisted Living Healthcare Facilities
  • Others
  • Regional Outlook (Revenue, USD Billion, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait
Show more
Product Code: 978-1-68038-886-2

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
    • 1.1.1. Segment Definitions
      • 1.1.1.1. Application Segment
      • 1.1.1.2. Type Segment
      • 1.1.1.3. Technology Segment
      • 1.1.1.4. Test Location Segment
      • 1.1.1.5. End Use Segment
  • 1.2. Regional Scope
  • 1.3. Estimates and Forecast Timeline
    • 1.3.1. Objectives
    • 1.3.2. Objective - 1
    • 1.3.3. Objective - 2
    • 1.3.4. Objective - 3
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information or Data Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Validation
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. List of Abbreviations

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Technology & Application Snapshot
  • 2.3. Test Location & Type Snapshot
  • 2.4. End Use Snapshot
  • 2.5. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Segmentation and Scope
  • 3.2. Market Lineage Outlook
    • 3.2.1. Parent Market Outlook
    • 3.2.2. Related/Ancillary Market Outlook
  • 3.3. Market Dynamics
  • 3.4. Market Drivers
    • 3.4.1. Growing Demand for Rapid and Decentralized Testing
    • 3.4.2. Rising Prevalence of Infectious Diseases
    • 3.4.3. Technological Advancements in Molecular Platforms
  • 3.5. Market Restraint Analysis
    • 3.5.1. High Cost of Molecular POC Devices and Consumables
    • 3.5.2. Regulatory and Quality Assurance Challenges
  • 3.6. Business Environment Analysis
    • 3.6.1. SWOT Analysis; By Factor (Political & Legal, Economic and Technological)
    • 3.6.2. Porter's Five Forces Analysis
    • 3.6.3. COVID-19 Impact Analysis

Chapter 4. Technology Business Analysis

  • 4.1. Point-of-Care Molecular Diagnostics market: Technology Movement Analysis
  • 4.2. PCR-based
    • 4.2.1. PCR-based Market, 2021 - 2033 (USD Billion)
  • 4.3. Genetic Sequencing-based
    • 4.3.1. Genetic Sequencing-based Market, 2021 - 2033 (USD Billion)
  • 4.4. Hybridization-based
    • 4.4.1. Hybridization-based Market, 2021 - 2033 (USD Billion)
  • 4.5. Microarray-based
    • 4.5.1. Microarray-based Market, 2021 - 2033 (USD Billion)

Chapter 5. Application Business Analysis

  • 5.1. Point-of-Care Molecular Diagnostics Market: Application Movement Analysis
  • 5.2. Infectious Diseases
    • 5.2.1. Infectious Diseases Market, 2021 - 2033 (USD Billion)
    • 5.2.2. HIV POC
      • 5.2.2.1. HIV POC Market, 2021 - 2033 (USD Billion)
    • 5.2.3. Clostridium difficile POC
      • 5.2.3.1. Clostridium difficile POC Market, 2021 - 2033 (USD Billion)
    • 5.2.4. HBV POC
      • 5.2.4.1. HBV POC Market, 2021 - 2033 (USD Billion)
    • 5.2.5. Pneumonia or Streptococcus associated infections
      • 5.2.5.1. Pneumonia or Streptococcus associated infections Market, 2021 - 2033 (USD Billion)
    • 5.2.6. Respiratory Syncytial Virus (RSV) POC
      • 5.2.6.1. Respiratory Syncytial Virus (RSV) POC Market, 2021 - 2033 (USD Billion)
    • 5.2.7. HPV POC
      • 5.2.7.1. HPV POC Market, 2021 - 2033 (USD Billion)
    • 5.2.8. Influenza/Flu POC
      • 5.2.8.1. Influenza/Flu POC Market, 2021 - 2033 (USD Billion)
    • 5.2.9. HCV POC
      • 5.2.9.1. HCV POC Market, 2021 - 2033 (USD Billion)
    • 5.2.10. MRSA POC
      • 5.2.10.1. MRSA POC Market, 2021 - 2033 (USD Billion)
    • 5.2.11. TB and drug-resistant TB POC
      • 5.2.11.1. TB and drug-resistant TB POC Market, 2021 - 2033 (USD Billion)
    • 5.2.12. HSV POC
      • 5.2.12.1. HSV POC Market, 2021 - 2033 (USD Billion)
    • 5.2.13. Other Infectious Diseases
      • 5.2.13.1. Other Infectious Diseases Market, 2021 - 2033 (USD Billion)
  • 5.3. Oncology
    • 5.3.1. Oncology Market, 2021 - 2033 (USD Billion)
  • 5.4. Hematology
    • 5.4.1. Hematology Market, 2021 - 2033 (USD Billion)
  • 5.5. Prenatal Testing
    • 5.5.1. Prenatal Testing Market, 2021 - 2033 (USD Billion)
  • 5.6. Endocrinology
    • 5.6.1. Endocrinology Market, 2021 - 2033 (USD Billion)
  • 5.7. Others
    • 5.7.1. Others Market, 2021 - 2033 (USD Billion)

Chapter 6. Test Location Business Analysis

  • 6.1. Point-of-Care Molecular Diagnostics Market: Test Location Movement Analysis
  • 6.2. OTC
    • 6.2.1. OTC Market, 2021 - 2033 (USD Billion)
  • 6.3. POC
    • 6.3.1. POC Market, 2021 - 2033 (USD Billion)

Chapter 7. End Use Business Analysis

  • 7.1. Point-of-Care Molecular Diagnostics Market: End Use Movement Analysis
  • 7.2. Decentralized Labs
    • 7.2.1. Decentralized Labs Market, 2021 - 2033 (USD Billion)
  • 7.3. Hospitals
    • 7.3.1. Hospitals Market, 2021 - 2033 (USD Billion)
  • 7.4. Homecare
    • 7.4.1. Home-care Market, 2021 - 2033 (USD Billion)
  • 7.5. Assisted Living Healthcare Facilities
    • 7.5.1. Assisted Living Healthcare Facilities Market, 2021 - 2033 (USD Billion)
  • 7.6. Others
    • 7.6.1. Others Market, 2021 - 2033 (USD Billion)

Chapter 8. Regional Business Analysis

  • 8.1. Point-of-Care Molecular Diagnostics Market Share By Region, 2025 & 2033
  • 8.2. North America
    • 8.2.1. North America Point-of-Care Molecular Diagnostics market, 2021 - 2033 (USD Billion)
    • 8.2.2. U.S.
      • 8.2.2.1. Key Country Dynamics
      • 8.2.2.2. Target Disease Prevalence
      • 8.2.2.3. Competitive Scenario
      • 8.2.2.4. Regulatory Framework
      • 8.2.2.5. Reimbursement Scenario
      • 8.2.2.6. U.S. Point-of-Care Molecular Diagnostics market, 2021 - 2033 (USD BILLION)
    • 8.2.3. Canada
      • 8.2.3.1. Key Country Dynamics
      • 8.2.3.2. Target Disease Prevalence
      • 8.2.3.3. Competitive Scenario
      • 8.2.3.4. Regulatory Framework
      • 8.2.3.5. Reimbursement Scenario
      • 8.2.3.6. Canada Point-of-Care Molecular Diagnostics market, 2021 - 2033 (USD Billion)
    • 8.2.4. Mexico
      • 8.2.4.1. Key Country Dynamics
      • 8.2.4.2. Target Disease Prevalence
      • 8.2.4.3. Competitive Scenario
      • 8.2.4.4. Regulatory Framework
      • 8.2.4.5. Reimbursement Scenario
      • 8.2.4.6. Mexico Point-of-Care Molecular Diagnostics market, 2021 - 2033 (USD Billion)
  • 8.3. Europe
    • 8.3.1. Europe Point-of-Care Molecular Diagnostics market, 2021 - 2033 (USD Billion)
    • 8.3.2. Germany
      • 8.3.2.1. Key Country Dynamics
      • 8.3.2.2. Target Disease Prevalence
      • 8.3.2.3. Competitive Scenario
      • 8.3.2.4. Regulatory Framework
      • 8.3.2.5. Reimbursement Scenario
      • 8.3.2.6. Germany Point-of-Care Molecular Diagnostics market, 2021 - 2033 (USD Billion)
    • 8.3.3. UK
      • 8.3.3.1. Key Country Dynamics
      • 8.3.3.2. Target Disease Prevalence
      • 8.3.3.3. Competitive Scenario
      • 8.3.3.4. Regulatory Framework
      • 8.3.3.5. Reimbursement Scenario
      • 8.3.3.6. UK Point-of-Care Molecular Diagnostics market, 2021 - 2033 (USD Billion)
    • 8.3.4. France
      • 8.3.4.1. Key Country Dynamics
      • 8.3.4.2. Target Disease Prevalence
      • 8.3.4.3. Competitive Scenario
      • 8.3.4.4. Regulatory Framework
      • 8.3.4.5. Reimbursement Scenario
      • 8.3.4.6. France Point-of-Care Molecular Diagnostics market, 2021 - 2033 (USD Billion)
    • 8.3.5. Italy
      • 8.3.5.1. Key Country Dynamics
      • 8.3.5.2. Target Disease Prevalence
      • 8.3.5.3. Competitive Scenario
      • 8.3.5.4. Regulatory Framework
      • 8.3.5.5. Reimbursement Scenario
      • 8.3.5.6. Italy Point-of-Care Molecular Diagnostics market, 2021 - 2033 (USD Billion)
    • 8.3.6. Spain
      • 8.3.6.1. Key Country Dynamics
      • 8.3.6.2. Target Disease Prevalence
      • 8.3.6.3. Competitive Scenario
      • 8.3.6.4. Regulatory Framework
      • 8.3.6.5. Reimbursement Scenario
      • 8.3.6.6. Spain Point-of-Care Molecular Diagnostics market, 2021 - 2033 (USD Billion)
    • 8.3.7. Denmark
      • 8.3.7.1. Key Country Dynamics
      • 8.3.7.2. Target Disease Prevalence
      • 8.3.7.3. Competitive Scenario
      • 8.3.7.4. Regulatory Framework
      • 8.3.7.5. Reimbursement Scenario
      • 8.3.7.6. Denmark Point-of-Care Molecular Diagnostics market, 2021 - 2033 (USD Billion)
    • 8.3.8. Sweden
      • 8.3.8.1. Key Country Dynamics
      • 8.3.8.2. Target Disease Prevalence
      • 8.3.8.3. Competitive Scenario
      • 8.3.8.4. Regulatory Framework
      • 8.3.8.5. Reimbursement Scenario
      • 8.3.8.6. Sweden Point-of-Care Molecular Diagnostics market, 2021 - 2033 (USD Billion)
    • 8.3.9. Norway
      • 8.3.9.1. Key Country Dynamics
      • 8.3.9.2. Target Disease Prevalence
      • 8.3.9.3. Competitive Scenario
      • 8.3.9.4. Regulatory Framework
      • 8.3.9.5. Reimbursement Scenario
      • 8.3.9.6. Norway Point-of-Care Molecular Diagnostics market, 2021 - 2033 (USD Billion)
  • 8.4. Asia Pacific
    • 8.4.1. Asia Pacific Point-of-Care Molecular Diagnostics market, 2021 - 2033 (USD Billion)
    • 8.4.2. Japan
      • 8.4.2.1. Key Country Dynamics
      • 8.4.2.2. Target Disease Prevalence
      • 8.4.2.3. Competitive Scenario
      • 8.4.2.4. Regulatory Framework
      • 8.4.2.5. Reimbursement Scenario
      • 8.4.2.6. Japan Point-of-Care Molecular Diagnostics market, 2021 - 2033 (USD Billion)
    • 8.4.3. China
      • 8.4.3.1. Key Country Dynamics
      • 8.4.3.2. Target Disease Prevalence
      • 8.4.3.3. Competitive Scenario
      • 8.4.3.4. Regulatory Framework
      • 8.4.3.5. Reimbursement Scenario
      • 8.4.3.6. China Point-of-Care Molecular Diagnostics market, 2021 - 2033 (USD Billion)
    • 8.4.4. India
      • 8.4.4.1. Key Country Dynamics
      • 8.4.4.2. Target Disease Prevalence
      • 8.4.4.3. Competitive Scenario
      • 8.4.4.4. Regulatory Framework
      • 8.4.4.5. Reimbursement Scenario
      • 8.4.4.6. India Point-of-Care Molecular Diagnostics market, 2021 - 2033 (USD Billion)
    • 8.4.5. South Korea
      • 8.4.5.1. Key Country Dynamics
      • 8.4.5.2. Target Disease Prevalence
      • 8.4.5.3. Competitive Scenario
      • 8.4.5.4. Regulatory Framework
      • 8.4.5.5. Reimbursement Scenario
      • 8.4.5.6. South Korea Point-of-Care Molecular Diagnostics market, 2021 - 2033 (USD Billion)
    • 8.4.6. Australia
      • 8.4.6.1. Key Country Dynamics
      • 8.4.6.2. Target Disease Prevalence
      • 8.4.6.3. Competitive Scenario
      • 8.4.6.4. Regulatory Framework
      • 8.4.6.5. Reimbursement Scenario
      • 8.4.6.6. Australia Point-of-Care Molecular Diagnostics market, 2021 - 2033 (USD Billion)
    • 8.4.7. Thailand
      • 8.4.7.1. Key Country Dynamics
      • 8.4.7.2. Target Disease Prevalence
      • 8.4.7.3. Competitive Scenario
      • 8.4.7.4. Regulatory Framework
      • 8.4.7.5. Reimbursement Scenario
      • 8.4.7.6. Thailand Point-of-Care Molecular Diagnostics market, 2021 - 2033 (USD Billion)
  • 8.5. Latin America
    • 8.5.1. Latin America Point-of-Care Molecular Diagnostics market, 2021 - 2033 (USD Billion)
    • 8.5.2. Brazil
      • 8.5.2.1. Key Country Dynamics
      • 8.5.2.2. Target Disease Prevalence
      • 8.5.2.3. Competitive Scenario
      • 8.5.2.4. Regulatory Framework
      • 8.5.2.5. Reimbursement Scenario
      • 8.5.2.6. Brazil Point-of-Care Molecular Diagnostics market, 2021 - 2033 (USD Billion)
    • 8.5.3. Argentina
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Target Disease Prevalence
      • 8.5.3.3. Competitive Scenario
      • 8.5.3.4. Regulatory Framework
      • 8.5.3.5. Reimbursement Scenario
      • 8.5.3.6. Argentina Point-of-Care Molecular Diagnostics market, 2021 - 2033 (USD Billion)
  • 8.6. MEA
    • 8.6.1. MEA Point-of-Care Molecular Diagnostics market, 2021 - 2033 (USD Billion)
    • 8.6.2. South Africa
      • 8.6.2.1. Key Country Dynamics
      • 8.6.2.2. Target Disease Prevalence
      • 8.6.2.3. Competitive Scenario
      • 8.6.2.4. Regulatory Framework
      • 8.6.2.5. Reimbursement Scenario
      • 8.6.2.6. South Africa Point-of-Care Molecular Diagnostics market, 2021 - 2033 (USD Billion)
    • 8.6.3. Saudi Arabia
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Target Disease Prevalence
      • 8.6.3.3. Competitive Scenario
      • 8.6.3.4. Regulatory Framework
      • 8.6.3.5. Reimbursement Scenario
      • 8.6.3.6. Saudi Arabia Point-of-Care Molecular Diagnostics market, 2021 - 2033 (USD Billion)
    • 8.6.4. UAE
      • 8.6.4.1. Key Country Dynamics
      • 8.6.4.2. Target Disease Prevalence
      • 8.6.4.3. Competitive Scenario
      • 8.6.4.4. Regulatory Framework
      • 8.6.4.5. Reimbursement Scenario
      • 8.6.4.6. UAE Point-of-Care Molecular Diagnostics market, 2021 - 2033 (USD Billion)
    • 8.6.5. Kuwait
      • 8.6.5.1. Key Country Dynamics
      • 8.6.5.2. Target Disease Prevalence
      • 8.6.5.3. Competitive Scenario
      • 8.6.5.4. Regulatory Framework
      • 8.6.5.5. Reimbursement Scenario
      • 8.6.5.6. Kuwait Point-of-Care Molecular Diagnostics market, 2021 - 2033 (USD Billion)

Chapter 9. Competitive Landscape

  • 9.1. Participant's overview
  • 9.2. Financial performance
  • 9.3. Participant categorization
    • 9.3.1. Market Leaders
    • 9.3.2. Point-of-Care Molecular Diagnostics Market Share Analysis, 2025
    • 9.3.3. Company Profiles
      • 9.3.3.1. Abbott
        • 9.3.3.1.1. Company Overview
        • 9.3.3.1.2. Financial Performance
        • 9.3.3.1.3. Product Benchmarking
        • 9.3.3.1.4. Strategic Initiatives
      • 9.3.3.2. F. Hoffmann-La Roche AG
        • 9.3.3.2.1. Company Overview
        • 9.3.3.2.2. Financial Performance
        • 9.3.3.2.3. Product Benchmarking
        • 9.3.3.2.4. Strategic Initiatives
      • 9.3.3.3. QIAGEN
        • 9.3.3.3.1. Company Overview
        • 9.3.3.3.2. Financial Performance
        • 9.3.3.3.3. Product Benchmarking
        • 9.3.3.3.4. Strategic Initiatives
      • 9.3.3.4. Danaher Corporation
        • 9.3.3.4.1. Company Overview
        • 9.3.3.4.2. Financial Performance
        • 9.3.3.4.3. Product Benchmarking
        • 9.3.3.4.4. Strategic Initiatives
      • 9.3.3.5. BIOMERIEUX
        • 9.3.3.5.1. Company Overview
        • 9.3.3.5.2. Financial Performance
        • 9.3.3.5.3. Product Benchmarking
        • 9.3.3.5.4. Strategic Initiatives
      • 9.3.3.6. OraSure Technologies Inc.
        • 9.3.3.6.1. Company Overview
        • 9.3.3.6.2. Financial Performance
        • 9.3.3.6.3. Product Benchmarking
        • 9.3.3.6.4. Strategic Initiatives
      • 9.3.3.7. binx health, inc.
        • 9.3.3.7.1. Company Overview
        • 9.3.3.7.2. Financial Performance
        • 9.3.3.7.3. Product Benchmarking
        • 9.3.3.7.4. Strategic Initiatives
      • 9.3.3.8. QuidelOrtho Corporation.
        • 9.3.3.8.1. Company Overview
        • 9.3.3.8.2. Financial Performance
        • 9.3.3.8.3. Product Benchmarking
        • 9.3.3.8.4. Strategic Initiatives
    • 9.3.4. Strategy Mapping
      • 9.3.4.1. Expansion
      • 9.3.4.2. Acquisition
      • 9.3.4.3. Collaborations
      • 9.3.4.4. Disease Type/Drug Class Launch
      • 9.3.4.5. Partnerships
      • 9.3.4.6. Others
Show more
Product Code: 978-1-68038-886-2

List of Tables

  • TABLE 1 List of abbreviation
  • TABLE 2 Global point-of-care molecular diagnostics market, by application, 2021 - 2033 (USD Billion)
  • TABLE 3 Global point-of-care molecular diagnostics market, by technology, 2021 - 2033 (USD Billion)
  • TABLE 4 Global point-of-care molecular diagnostics market, by test location, 2021 - 2033 (USD Billion)
  • TABLE 5 Global point -of-care molecular diagnostics market, by end use, 2021 - 2033 (USD Billion)
  • TABLE 6 Global point -of-care molecular diagnostics market, by region, 2021 - 2033 (USD Billion)
  • TABLE 7 North America point -of-care molecular diagnostics market, by country, 2021 - 2033 (USD Billion)
  • TABLE 8 North America point -of-care Molecular Diagnostics Market, by application, 2021 - 2033 (USD Billion)
  • TABLE 9 North America point -of-care Molecular Diagnostics Market, by technology, 2021 - 2033 (USD Billion)
  • TABLE 10 North America point -of-care Molecular Diagnostics Market, by test location, 2021 - 2033 (USD Billion)
  • TABLE 11 North America point -of-care Molecular Diagnostics Market, by end use, 2021 - 2033 (USD Billion)
  • TABLE 12 U.S. point-of-care molecular diagnostics market, by application, 2021 - 2033 (USD Billion)
  • TABLE 13 U.S. point-of-care molecular diagnostics market by technology, 2021 - 2033 (USD Billion)
  • TABLE 14 U.S. point-of-care molecular diagnostics market, by test location, 2021 - 2033 (USD Billion)
  • TABLE 15 U.S. point-of-care molecular diagnostics market, by end use, 2021 - 2033 (USD Billion)
  • TABLE 16 Canada point-of-care molecular diagnostics market, by application, 2021 - 2033 (USD Billion)
  • TABLE 17 Canada point-of-care molecular diagnostics market, by technology, 2021 - 2033 (USD Billion)
  • TABLE 18 Canada point-of-care molecular diagnostics market, by test location, 2021 - 2033 (USD Billion)
  • TABLE 19 Canada point-of-care molecular diagnostics market, by end use, 2021 - 2033 (USD Billion)
  • TABLE 20 Mexico point-of-care molecular diagnostics market, by application, 2021 - 2033 (USD Billion)
  • TABLE 21 Mexico point-of-care molecular diagnostics market, by technology, 2021 - 2033 (USD Billion)
  • TABLE 22 Mexico point-of-care molecular diagnostics market, by test location, 2021 - 2033 (USD Billion)
  • TABLE 23 Mexico point-of-care molecular diagnostics market, by end use, 2021 - 2033 (USD Billion)
  • TABLE 24 Europe Point-of-care molecular diagnostics market, by country, 2021 - 2033 (USD Billion)
  • TABLE 25 Europe Point-of-care molecular diagnostics market, by application, 2021 - 2033 (USD Billion)
  • TABLE 26 Europe Point-of-care molecular diagnostics market, by technology, 2021 - 2033 (USD Billion)
  • TABLE 27 Europe Point-of-care molecular diagnostics market, by test location, 2021 - 2033 (USD Billion)
  • TABLE 28 Europe Point-of-care molecular diagnostics market, by end use, 2021 - 2033 (USD Billion)
  • TABLE 29 Germany Point-of-care molecular diagnostics market, by application, 2021 - 2033 (USD Billion)
  • TABLE 30 Germany Point-of-care molecular diagnostics market, by technology, 2021 - 2033 (USD Billion)
  • TABLE 31 Germany Point-of-care molecular diagnostics market, by test location, 2021 - 2033 (USD Billion)
  • TABLE 32 Germany Point-of-care molecular diagnostics market, by end use, 2021 - 2033 (USD Billion)
  • TABLE 33 UK Point-of-care molecular diagnostics market, by application, 2021 - 2033 (USD Billion)
  • TABLE 34 UK Point-of-care molecular diagnostics market, by technology, 2021 - 2033 (USD Billion)
  • TABLE 35 UK Point-of-care molecular diagnostics market, by test location, 2021 - 2033 (USD Billion)
  • TABLE 36 UK Point-of-care molecular diagnostics market, by end use, 2021 - 2033 (USD Billion)
  • TABLE 37 France Point-of-care molecular diagnostics market, by application, 2021 - 2033 (USD Billion)
  • TABLE 38 France Point-of-care molecular diagnostics market, by technology, 2021 - 2033 (USD Billion)
  • TABLE 39 France Point-of-care molecular diagnostics market, by test location, 2021 - 2033 (USD Billion)
  • TABLE 40 France Point-of-care molecular diagnostics market, by end use, 2021 - 2033 (USD Billion)
  • TABLE 41 Italy Point-of-care molecular diagnostics market, by application, 2021 - 2033 (USD Billion)
  • TABLE 42 Italy Point-of-care molecular diagnostics market, by technology, 2021 - 2033 (USD Billion)
  • TABLE 43 Italy Point-of-care molecular diagnostics market, by test location, 2021 - 2033 (USD Billion)
  • TABLE 44 Italy Point-of-care molecular diagnostics market, by end use, 2021 - 2033 (USD Billion)
  • TABLE 45 Spain Point-of-care molecular diagnostics market, by application, 2021 - 2033 (USD Billion)
  • TABLE 46 Spain Point-of-care molecular diagnostics market, by technology, 2021 - 2033 (USD Billion)
  • TABLE 47 Spain Point-of-care molecular diagnostics market, by test location, 2021 - 2033 (USD Billion)
  • TABLE 48 Spain Point-of-care molecular diagnostics market, by end use, 2021 - 2033 (USD Billion)
  • TABLE 49 Denmark Point-of-care molecular diagnostics market, by application, 2021 - 2033 (USD Billion)
  • TABLE 50 Denmark Point-of-care molecular diagnostics market, by technology, 2021 - 2033 (USD Billion)
  • TABLE 51 Denmark Point-of-care molecular diagnostics market, by test location, 2021 - 2033 (USD Billion)
  • TABLE 52 Denmark Point-of-care molecular diagnostics market, by end use, 2021 - 2033 (USD Billion)
  • TABLE 53 Sweden Point-of-care molecular diagnostics market, by application, 2021 - 2033 (USD Billion)
  • TABLE 54 Sweden Point-of-care molecular diagnostics market, by technology, 2021 - 2033 (USD Billion)
  • TABLE 55 Sweden Point-of-care molecular diagnostics market, by test location, 2021 - 2033 (USD Billion)
  • TABLE 56 Sweden Point-of-care molecular diagnostics market, by end use, 2021 - 2033 (USD Billion)
  • TABLE 57 Norway Point-of-care molecular diagnostics market, by application, 2021 - 2033 (USD Billion)
  • TABLE 58 Norway Point-of-care molecular diagnostics market, by technology, 2021 - 2033 (USD Billion)
  • TABLE 59 Norway Point-of-care molecular diagnostics market, by test location, 2021 - 2033 (USD Billion)
  • TABLE 60 Norway Point-of-care molecular diagnostics market, by end use, 2021 - 2033 (USD Billion)
  • TABLE 61 Asia Pacific Point-of-care molecular diagnostics market, by country, 2021 - 2033 (USD Billion)
  • TABLE 62 Asia Pacific Point-of-care molecular diagnostics market, by application, 2021 - 2033 (USD Billion)
  • TABLE 63 Asia Pacific Point-of-care molecular diagnostics market, by technology, 2021 - 2033 (USD Billion)
  • TABLE 64 Asia Pacific Point-of-care molecular diagnostics market, by test location, 2021 - 2033 (USD Billion)
  • TABLE 65 Asia Pacific Point-of-care molecular diagnostics market, by end use, 2021 - 2033 (USD Billion)
  • TABLE 66 Japan Point-of-care molecular diagnostics market, by application, 2021 - 2033 (USD Billion)
  • TABLE 67 Japan Point-of-care molecular diagnostics market, by technology, 2021 - 2033 (USD Billion)
  • TABLE 68 Japan Point-of-care molecular diagnostics market, by test location, 2021 - 2033 (USD Billion)
  • TABLE 69 Japan Point-of-care molecular diagnostics market, by end use, 2021 - 2033 (USD Billion)
  • TABLE 70 China Point-of-care molecular diagnostics market, by application, 2021 - 2033 (USD Billion)
  • TABLE 71 China Point-of-care molecular diagnostics market, by technology, 2021 - 2033 (USD Billion)
  • TABLE 72 China Point-of-care molecular diagnostics market, by test location, 2021 - 2033 (USD Billion)
  • TABLE 73 China Point-of-care molecular diagnostics market, by end use, 2021 - 2033 (USD Billion)
  • TABLE 74 India Point-of-care molecular diagnostics market, by application, 2021 - 2033 (USD Billion)
  • TABLE 75 India Point-of-care molecular diagnostics market, by technology, 2021 - 2033 (USD Billion)
  • TABLE 76 India Point-of-care molecular diagnostics market, by test location, 2021 - 2033 (USD Billion)
  • TABLE 77 India Point-of-care molecular diagnostics market, by end use, 2021 - 2033 (USD Billion)
  • TABLE 78 Australia Point-of-care molecular diagnostics market, by application, 2021 - 2033 (USD Billion)
  • TABLE 79 Australia Point-of-care molecular diagnostics market, by technology, 2021 - 2033 (USD Billion)
  • TABLE 80 Australia Point-of-care molecular diagnostics market, by test location, 2021 - 2033 (USD Billion)
  • TABLE 81 Australia Point-of-care molecular diagnostics market, by end use, 2021 - 2033 (USD Billion)
  • TABLE 82 South Korea Point-of-care molecular diagnostics market, by application, 2021 - 2033 (USD Billion)
  • TABLE 83 South Korea Point-of-care molecular diagnostics market, by technology, 2021 - 2033 (USD Billion)
  • TABLE 84 South Korea Point-of-care molecular diagnostics market, by test location, 2021 - 2033 (USD Billion)
  • TABLE 85 South Korea Point-of-care molecular diagnostics market, by end use, 2021 - 2033 (USD Billion)
  • TABLE 86 Thailand Point-of-care molecular diagnostics market, by application, 2021 - 2033 (USD Billion)
  • TABLE 87 Thailand Point-of-care molecular diagnostics market, by technology, 2021 - 2033 (USD Billion)
  • TABLE 88 Thailand Point-of-care molecular diagnostics market, by test location, 2021 - 2033 (USD Billion)
  • TABLE 89 Thailand Point-of-care molecular diagnostics market, by end use, 2021 - 2033 (USD Billion)
  • TABLE 90 Latin America Point-of-care molecular diagnostics market, by country, 2021 - 2033 (USD Billion)
  • TABLE 91 Latin America Point-of-care molecular diagnostics market, by application, 2021 - 2033 (USD Billion)
  • TABLE 92 Latin America Point-of-care molecular diagnostics market, by technology, 2021 - 2033 (USD Billion)
  • TABLE 93 Latin America Point-of-care molecular diagnostics market, by test location, 2021 - 2033 (USD Billion)
  • TABLE 94 Latin America Point-of-care molecular diagnostics market, by end use, 2021 - 2033 (USD Billion)
  • TABLE 95 Brazil Point-of-care molecular diagnostics market, by application, 2021 - 2033 (USD Billion)
  • TABLE 96 Brazil Point-of-care molecular diagnostics market, by technology, 2021 - 2033 (USD Billion)
  • TABLE 97 Brazil Point-of-care molecular diagnostics market, by test location, 2021 - 2033 (USD Billion)
  • TABLE 98 Brazil Point-of-care molecular diagnostics market, by end use, 2021 - 2033 (USD Billion)
  • TABLE 99 Argentina Point-of-care molecular diagnostics market, by application, 2021 - 2033 (USD Billion)
  • TABLE 100 Argentina Point-of-care molecular diagnostics market, by technology, 2021 - 2033 (USD Billion)
  • TABLE 101 Argentina Point-of-care molecular diagnostics market, by test location, 2021 - 2033 (USD Billion)
  • TABLE 102 Argentina Point-of-care molecular diagnostics market, by end use, 2021 - 2033 (USD Billion)
  • TABLE 103 MEA Point-of-care molecular diagnostics market, by country, 2021 - 2033 (USD Billion)
  • TABLE 104 MEA Point-of-care molecular diagnostics market, by application, 2021 - 2033 (USD Billion)
  • TABLE 105 MEA Point-of-care molecular diagnostics market, by technology, 2021 - 2033 (USD Billion)
  • TABLE 106 MEA Point-of-care molecular diagnostics market, by test location, 2021 - 2033 (USD Billion)
  • TABLE 107 MEA Point-of-care molecular diagnostics market, by end use, 2021 - 2033 (USD Billion)
  • TABLE 108 South Africa Point-of-care molecular diagnostics market, by application, 2021 - 2033 (USD Billion)
  • TABLE 109 South Africa Point-of-care molecular diagnostics market, by technology, 2021 - 2033 (USD Billion)
  • TABLE 110 South Africa Point-of-care molecular diagnostics market, by test location, 2021 - 2033 (USD Billion)
  • TABLE 111 South Africa Point-of-care molecular diagnostics market, by end use, 2021 - 2033 (USD Billion)
  • TABLE 112 Saudi Arabia Point-of-care molecular diagnostics market, by application, 2021 - 2033 (USD Billion)
  • TABLE 113 Saudi Arabia Point-of-care molecular diagnostics market, by technology, 2021 - 2033 (USD Billion)
  • TABLE 114 Saudi Arabia Point-of-care molecular diagnostics market, by test location, 2021 - 2033 (USD Billion)
  • TABLE 115 Saudi Arabia Point-of-care molecular diagnostics market, by end use, 2021 - 2033 (USD Billion)
  • TABLE 116 UAE Point-of-care molecular diagnostics market, by application, 2021 - 2033 (USD Billion)
  • TABLE 117 UAE Point-of-care molecular diagnostics market, by technology, 2021 - 2033 (USD Billion)
  • TABLE 118 UAE Point-of-care molecular diagnostics market, by test location, 2021 - 2033 (USD Billion)
  • TABLE 119 UAE Point-of-care molecular diagnostics market, by end use, 2021 - 2033 (USD Billion)
  • TABLE 120 Kuwait Point-of-care molecular diagnostics market, by application, 2021 - 2033 (USD Billion)
  • TABLE 121 Kuwait Point-of-care molecular diagnostics market, by technology, 2021 - 2033 (USD Billion)
  • TABLE 122 Kuwait Point-of-care molecular diagnostics market, by test location, 2021 - 2033 (USD Billion)
  • TABLE 123 Kuwait Point-of-care molecular diagnostics market, by end use, 2021 - 2033 (USD Billion)

List of Figures

  • FIG. 1 Point-of-care molecular diagnostics market Segmentation
  • FIG. 2 Global Point-of-care molecular diagnostics market, 2021 - 2033 (USD Billion)
  • FIG. 3 Point-of-care molecular diagnostics market Dynamics
  • FIG. 4 Key Opportunities Prioritized, 2021
  • FIG. 5 Point-of-care molecular diagnostics market - Porter's Analysis
  • FIG. 6 Point-of-care molecular diagnostics market - PESTEL Analysis
  • FIG. 7 Point-of-care molecular diagnostics revenue share, by application, 2025 & 2033
  • FIG. 8 POC Mdx Infectious Diseases Market, 2021 - 2033 (USD Billion)
  • FIG. 9 POC Mdx Oncology Market, 2021 - 2033 (USD Billion)
  • FIG. 10 POC Mdx Hematology Market, 2021 - 2033 (USD Billion)
  • FIG. 11 POC Mdx Prenatal Testing Market, 2021 - 2033 (USD Billion)
  • FIG. 12 POC Mdx Endocrinology Market, 2021 - 2033 (USD Billion)
  • FIG. 13 POC Mdx Other Applications Market, 2021 - 2033 (USD Billion)
  • FIG. 14 Point-Of-Care Molecular Diagnostics Revenue Share, By Technology, 2025 & 2033
  • FIG. 15 POC Mdx PCR-Based Market, 2021 - 2033 (USD Billion)
  • FIG. 16 POC Mdx Genetic Sequencing-Based Market, 2021 - 2033 (USD Billion)
  • FIG. 17 POC Mdx Hybridization-Based Market, 2021 - 2033 (USD Billion)
  • FIG. 18 POC Mdx Microarray-Based Market, 2021 - 2033 (USD Billion)
  • FIG. 19 Point-Of-Care Molecular Diagnostics Revenue Share, By Test Location, 2025 & 2033
  • FIG. 20 POC Mdx Over-The-Counter Market, 2021 - 2033 (USD Billion)
  • FIG. 21 POC Mdx Point-Of-Care Market, 2021 - 2033 (USD Billion)
  • FIG. 22 Point-Of-Care Molecular Diagnostics Revenue Share, By End Use, 2025 & 2033
  • FIG. 23 POC Mdx Decentralized Labs Market, 2021 - 2033 (USD Billion)
  • FIG. 24 POC Mdx Hospitals Market, 2021 - 2033 (USD Billion)
  • FIG. 25 POC Mdx Home-Care Market, 2021 - 2033 (USD Billion)
  • FIG. 26 POC Mdx Assisted Living Healthcare Facilities Market, 2021 - 2033 (USD Billion)
  • FIG. 27 POC Mdx Other End Uses Market, 2021 - 2033 (USD Billion)
  • FIG. 28 Point-Of-Care Molecular Diagnostics Revenue Share, By Region, 2025 & 2033
  • FIG. 29 North America Point-of-care molecular diagnostics market, 2021 - 2033 (USD Billion)
  • FIG. 30 US Point-of-care molecular diagnostics market, 2021 - 2033 (USD Billion)
  • FIG. 31 Canada Point-of-care molecular diagnostics market, 2021 - 2033 (USD Billion)
  • FIG. 32 Mexico Point-of-care molecular diagnostics market, 2021 - 2033 (USD Billion)
  • FIG. 33 Europe Point-of-care molecular diagnostics market, 2021 - 2033 (USD Billion)
  • FIG. 34 Germany Point-of-care molecular diagnostics market, 2021 - 2033 (USD Billion)
  • FIG. 35 UK Point-of-care molecular diagnostics market, 2021 - 2033 (USD Billion)
  • FIG. 36 France Point-of-care molecular diagnostics market, 2021 - 2033 (USD Billion)
  • FIG. 37 Italy Point-of-care molecular diagnostics market, 2021 - 2033 (USD Billion)
  • FIG. 38 Spain Point-of-care molecular diagnostics market, 2021 - 2033 (USD Billion)
  • FIG. 39 Denmark Point-of-care molecular diagnostics market, 2021 - 2033 (USD Billion)
  • FIG. 40 Sweden Point-of-care molecular diagnostics market, 2021 - 2033 (USD Billion)
  • FIG. 41 Norway Point-of-care molecular diagnostics market, 2021 - 2033 (USD Billion)
  • FIG. 42 Asia Pacific Point-of-care molecular diagnostics market, 2021 - 2033 (USD Billion)
  • FIG. 43 Japan Point-of-care molecular diagnostics market, 2021 - 2033 (USD Billion)
  • FIG. 44 China Point-of-care molecular diagnostics market, 2021 - 2033 (USD Billion)
  • FIG. 45 India Point-of-care molecular diagnostics market, 2021 - 2033 (USD Billion)
  • FIG. 46 Australia Point-of-care molecular diagnostics market, 2021 - 2033 (USD Billion)
  • FIG. 47 South Korea Point-of-care molecular diagnostics market, 2021 - 2033 (USD Billion)
  • FIG. 48 Thailand Point-of-care molecular diagnostics market, 2021 - 2033 (USD Billion)
  • FIG. 49 Latin America Point-of-care molecular diagnostics market, 2021 - 2033 (USD Billion)
  • FIG. 50 Brazil Point-of-care molecular diagnostics market, 2021 - 2033 (USD Billion)
  • FIG. 51 Argentina Point-of-care molecular diagnostics market, 2021 - 2033 (USD Billion)
  • FIG. 52 MEA Point-of-care molecular diagnostics market, 2021 - 2033 (USD Billion)
  • FIG. 53 South Africa Point-of-care molecular diagnostics market, 2021 - 2033 (USD Billion)
  • FIG. 54 Saudi Arabia Point-of-care molecular diagnostics market, 2021 - 2033 (USD Billion)
  • FIG. 55 UAE Point-of-care molecular diagnostics market, 2021 - 2033 (USD Billion)
  • FIG. 56 Kuwait Point-of-care molecular diagnostics market, 2021 - 2033 (USD Billion)
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!